Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-22-002451
Filing Date
2022-11-14
Accepted
2022-11-14 16:21:43
Documents
55
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bdpt_10q.htm   iXBRL 10-Q 696131
2 CERTIFICATION bdpt_ex311.htm EX-31.1 9522
3 CERTIFICATION bdpt_ex312.htm EX-31.2 8611
4 CERTIFICATION bdpt_ex321.htm EX-32.1 3539
5 CERTIFICATION bdpt_ex322.htm EX-32.2 2845
11 bdpt_10qimg1.jpg GRAPHIC 4146
  Complete submission text file 0001640334-22-002451.txt   3273902

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20220930.xsd EX-101.SCH 33927
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20220930_lab.xml EX-101.LAB 194096
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20220930_cal.xml EX-101.CAL 36159
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20220930_pre.xml EX-101.PRE 169657
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20220930_def.xml EX-101.DEF 100018
49 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_10q_htm.xml XML 456958
Mailing Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128 (702) 659-8829
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

EIN.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54949 | Film No.: 221385891
SIC: 2834 Pharmaceutical Preparations